Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2Q09

Crystal structure of Imidazolonepropionase from environmental sample with bound inhibitor 3-(2,5-Dioxo-imidazolidin-4-yl)-propionic acid

Summary for 2Q09
Entry DOI10.2210/pdb2q09/pdb
Related2GOK 2OOF 2PUZ
DescriptorImidazolonepropionase, FE (III) ION, 3-[(4S)-2,5-DIOXOIMIDAZOLIDIN-4-YL]PROPANOIC ACID, ... (4 entities in total)
Functional Keywords9252h, nysgxrc, imidazolonepropionase, 3-(2, 5-dioxo-imidazolidin-4yl)-propionic acid, psi-2 community, structural genomics, protein structure initiative, new york sgx research center for structural genomics, hydrolase
Biological sourceunidentified
Total number of polymer chains1
Total formula weight45937.59
Authors
Tyagi, R.,Eswaramoorthy, S.,Burley, S.K.,Swaminathan, S.,New York SGX Research Center for Structural Genomics (NYSGXRC) (deposition date: 2007-05-21, release date: 2007-06-05, Last modification date: 2024-10-30)
Primary citationTyagi, R.,Eswaramoorthy, S.,Burley, S.K.,Raushel, F.M.,Swaminathan, S.
A common catalytic mechanism for proteins of the HutI family.
Biochemistry, 47:5608-5615, 2008
Cited by
PubMed Abstract: Imidazolonepropionase (HutI) (imidazolone-5-propanote hydrolase, EC 3.5.2.7) is a member of the amidohydrolase superfamily and catalyzes the conversion of imidazolone-5-propanoate to N-formimino-L-glutamate in the histidine degradation pathway. We have determined the three-dimensional crystal structures of HutI from Agrobacterium tumefaciens (At-HutI) and an environmental sample from the Sargasso Sea Ocean Going Survey (Es-HutI) bound to the product [ N-formimino-L-glutamate (NIG)] and an inhibitor [3-(2,5-dioxoimidazolidin-4-yl)propionic acid (DIP)], respectively. In both structures, the active site is contained within each monomer, and its organization displays the landmark feature of the amidohydrolase superfamily, showing a metal ligand (iron), four histidines, and one aspartic acid. A catalytic mechanism involving His265 is proposed on the basis of the inhibitor-bound structure. This mechanism is applicable to all HutI forms.
PubMed: 18442260
DOI: 10.1021/bi800180g
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.97 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon